MSB 7.69% $1.19 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-153

  1. 1,609 Posts.
    lightbulb Created with Sketch. 1691
    Don't mind at all if they do!! But overwhelming efficacy is, well, overwhelming, isn't it?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.